CME vs EBS · P/E 22, rev $6.52B vs rev $1.04B
CME Group Inc (CME) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported CME revenue for 2025-12-31 was $6.52B. Net income was $4.07B. Revenue was up 6.4% from 2024-12-31 to 2025-12-31. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
CME currently screens at market cap $91.25B and trailing P/E 21.9. EBS currently screens at market cap $416.4M.
Not investment advice. Open the CME and EBS stock pages for the full models.
Not investment advice.